Month: January 2024

Oslo, Norway, 12 January 2024 Interoil Exploration and Production ASA (the “Company”) refers to the resolution made by the Company’s Extraordinary General Meeting on 18 December 2023 to increase the share capital by NOK 3.00 through issue of six (6) new shares each with a par value of NOK 0.50. The share capital increase related to the share issue has been registered with the Norwegian Register of Enterprises. Following such registration, the Company’s registered share capital is NOK 100,672,140, divided into 201,344,280 shares, each with a par value of NOK 0.50. The share capital increase was done to facilitate a reverse share split (share consolidation) of the Company’s shares in the ratio of 10:1 to meet Oslo Børs’ requirements of a minimum share value of NOK 1 per share. The Company will issue a separate...

Approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of AGAMREE® in the United Kingdom follows marketing authorization for this medicine in the EU and U.S. MHRA acknowledges safety benefits of AGAMREE with regards to preserving bone health and maintaining growth compared to standard of care corticosteroids Launches of AGAMREE in Europe, with Germany taking the lead, are planned to start in Q1-2024Pratteln, Switzerland, January 12, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that AGAMREE® (vamorolone) has been approved in the United Kingdom (UK) for the treatment of Duchenne muscular dystrophy (DMD) in patients 4 years of age and older, independent of the underlying mutation and ambulatory status. The UK’s MHRA, adopting the view of the European Medicines Agency (EMA), acknowledged clinically important...

The total number of digital subscriptions of AS Ekspress Grupp increased by 41% in the Baltic States year-over-year (4th quarter: 15%) and totalled 207,328 at the end of December.The number of digital subscriptions of AS Delfi Meedia that publishes the news portal Delfi, newspapers Eesti Päevaleht, Maaleht, Eesti Ekspress and several popular magazines increased by 20% year-over-year (4th quarter: 4%) and totalled 102,793. The number of digital subscriptions of AS Õhtuleht Kirjastus, 50% of which is owned by Ekspress Grupp, increased by 10% year-over-year (4th quarter: -2%) and totalled 24,875. The number of digital subscriptions of Geenius Meedia OÜ increased by 25% year-over-year (4th quarter: 8%) and totalled 6,998. In Latvia, the number of digital subscriptions of Delfi A/S increased by 87% year-over-year (4th quarter: 31%) and totalled...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Jan. 11, 2024 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV:CMC; OTCQB:CWSFF) (“Cielo” or the “Company”), a waste-to-fuel environmental technology company, announces today that it has extended the date by which it is required to pay royalties (the “Royalties”) to July 3, 2024. BACKGROUND In 2018, the Company had undertaken an early warrant exercise incentive program, issuing a $0.0875 fixed rate royalty for each of the 10,162,500 warrants that were exercised. The deadline to pay the Royalties was originally July 3, 2020, which was extended in July 2020 and again in July 2022, requiring repayment in January 2024. The Company is pleased to have received the required approval from the...

KUALA LUMPUR, Malaysia, Jan. 11, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) today announced the pricing of a public offering of 2,200,000 the Company’s ordinary shares and accompanying Series A warrants to purchase up to 2,200,000 ordinary shares (“Series A Warrants”) and Series B warrants to purchase up to 2,200,000 ordinary shares (“Series B Warrants”, together with Series A Warrants, collectively the “Series Warrants”) at a combined offering price of $1.25 per ordinary share and associated Series Warrants. The Series Warrants have an exercise price of $1.25 per share and will be immediately exercisable upon issuance. The Series A Warrants will expire five years following the initial exercise date, and the Series B Warrants will expire eighteen months following the initial exercise...

Netanya, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) — Silynxcom Ltd. (the “Company” or “Silynxcom”) (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication headset devices as well as other communication accessories, today announced the pricing of its initial public offering of 1,250,000 ordinary shares at a price to the public of $4.00 per share, for gross proceeds of $5,000,000, before deducting underwriting discounts and offering expenses. In addition, Silynxcom has granted the underwriters a 45-day option to purchase up to an additional 187,500 ordinary shares to cover over-allotments at the public offering price, less the underwriting discount. The Company intends to use the proceeds for marketing, business development, research and development, working capital and general corporate purposes. The...

Luxury home community offers cottage-style homes with personal garden areas in the highly desirable Rose Hill neighborhoodCentre Cottages by Toll Brothers“With the grand opening of our professionally decorated Dewberry model home at Centre Cottages, home buyers have the opportunity to experience the luxury, comfort, and unique design elements that set these Toll Brothers homes apart,” said Kelley Moldstad, Group President of Toll Brothers in Washington and Oregon.Centre Cottages by Toll BrothersToll Brothers opens its new model home at the luxury Centre Cottages community in Kirkland, Washington.KIRKLAND, Wash., Jan. 11, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, is pleased to announce the grand opening of its Dewberry model home at Centre...

MEXICO CITY, Jan. 11, 2024 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, today announced its guidance for the first quarter and full year 2024. For 2024, Volaris remains focused on executing its business plan to serve robust demand in its domestic and international markets and drive profitable growth despite constraints due to accelerated GTF engine preventive inspections. The Company’s priorities for the year are: (i) ensuring the safety of our ambassadors and customers, (ii) driving profitability, and (iii) optimizing network reliability. Additionally, we maintain the 2023 guidance provided to the market on October 10, 2023. For the first quarter...

MOUNTAIN VIEW, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) — Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, proudly announces the US launch of its next-generation platform Iridex 532® and Iridex 577® Lasers alongside its 35th anniversary celebration. The announcement was made ahead of their official showcase at the Hawaiian Eye and Retina 2024 Meeting from January 13-19, 2024. Both lasers harness multiple treatment modes including continuous-wave and Iridex’ patented MicroPulse® Technology and an intuitive touchscreen interface providing a wide range of clinical control options and features to optimize the treatment of retinal disorders and glaucoma. David Bruce, President and CEO of Iridex Corporation, said, “The launch of the new Iridex 532 and Iridex 577 Lasers stands...